Novavax (NVAX) Lags on Q2 Earnings & Sales, Cuts '24 Outlook
NVAXNovavax(NVAX) ZACKS·2024-08-10 00:10

Novavax (NVAX) posted earnings per share of 99 cents in second-quarter 2024, missing the Zacks Consensus Estimate of 1.82.However,earningsrose711.82. However, earnings rose 71% year over year.Revenues in the quarter amounted to 415.5 million, also missing the Zacks Consensus Estimate of 453.7million.Thetoplinedeclined2453.7 million. The top line declined 2% on a year-over-year basis.Quarter in DetailIn the reported quarter, the company recorded 19.9 million in product sales compared with $285.2 million in the year-ago quarter. While this reported figure did bea ...